Navigation Links
ABC²'s Research Showcase: INSIGhT - The First-Ever Adaptive Clinical Trial for Glioblastoma
Date:10/6/2017

On Tuesday, October 24th, ABC² (Accelerate Brain Cancer Cure) will host a lunch discussion and webinar on INSIGhT, the first-ever adaptive clinical trial for glioblastoma (GBM). The featured speaker will be Dr. Brian Alexander, INSIGhT Principal Investigator, Dana-Farber Cancer Institute. The event is free and open to the public, but registration is required.

WHAT: ABC² Brain Cancer Research Lunch & Learn

WHEN: October 24, 2017, 11:30 AM – 1:30 PM

WHERE: The Case Foundation, 1717 Rhode Island Ave. NW, Suite 700, Washington, DC 20036

11:30 am – 11:50 am – “Next Generation Clinical Trials and Personalized Medicine”

Speaker: Max Wallace, CEO, ABC²

11:50 am - 12:30 pm – Lunch

12:30 pm – 1:30 pm – “INSIGhT Adaptive Clinical Trial for GBM” (For those unable to attend in person, a live webcast of the discussion is scheduled to begin at 12:30 pm EST on Facebook Live)

Speakers: Dr. Brian Alexander, INSIGhT Principal Investigator, Dana-Farber Cancer Institute and David Sandak, Senior Vice President, Strategy and Research, ABC²
Moderator: Max Wallace, CEO, ABC²

INSIGhT is the first-ever adaptive clinical trial in brain cancer. It matches targeted therapies with the patients most likely to benefit from them.

Dana Farber is leading a 10-institution consortium (Massachusetts General Hospital, The University of Alabama at Birmingham, Mayo Clinic, Columbia, Cleveland Clinic, MD Anderson, University of Pittsburgh, Utah/Huntsman, and University of Virginia) that will test multiple drugs in newly diagnosed patients in a rapidly adaptive environment. Five institutions in the consortium have now begun recruiting patients and the others are soon to follow.

As part of this, ABC² has joined with three pharmaceutical companies (Eli Lilly, Celgene and Puma Biotechnology) to fund the trial and ABC²'s Allele system does the front-end molecular analysis placing patients into the treatment arm most suitable for their individual tumor.

"In the past, glioblastoma patients have faced limited treatment options and a grim prognosis," says Max Wallace, CEO of ABC². "We're focused on developing the most promising and tailored treatments for patients today - and that's the aim of INSIGhT."

To RSVP for the lunch discussion, please click HERE or email info(at)abc2(dot)org by October 13th.

2017 Science Salon Series Sponsored by Genentech

About ABC² (Accelerate Brain Cancer Cure)
ABC² is focused on speeding the discovery of a cure for brain cancer. By applying an aggressive, venture funding approach not typically seen in the nonprofit sector, ABC² closes current gaps in funding in order to catalyze research and rapidly bring new therapies to patients. ABC² has awarded more than 100 grants totaling $20 million in brain tumor research funding to highly qualified investigators and physician-scientists from 54 institutions and companies. Since its founding in 2001, ABC² has helped bring 30 different treatments into the clinic. To learn more, visit http://www.abc2.org.

# # #

Read the full story at http://www.prweb.com/releases/2017/10/prweb14765332.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. LabRoots Launches Month-long Campaign in Efforts to Push Breast Cancer Research Forward
2. ResearchDx and Menarini Silicon Biosystems Launch DEPArray HER2 for Breast and GEA Cancers
3. Central Research Laboratories® Introduces VERSA® – An Innovative, Infinitely Customizable Telemanipulator for Remote-Handling Systems
4. Thermo Fisher Scientific Advances RAS Research Panel on Applied Biosystem
5. Genedata Screener Strengthens Collaborative Research at Axxam
6. HumanZyme® Announces Human Cell-Expressed Interferon gamma for Immunology and Immunotherapy Research Applications
7. Outstanding Early-career Work Eligible for Rising Researcher Awards
8. Sterlitech to Provide Larger Scale Membrane Skids for Research and Industry Customers
9. BioPharma Institute Launches 5 Top U.S. Pharmaceutical & Clinical Research Industry Regulatory Compliance Courses as Parent Company Celebrates 20th Anniversary
10. Maryland Soybean Board Seeks Research Proposals
11. Noblis Releases Online Portal for Bioinformatics Research and Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... DuPont Pioneer and recently formed ... entered into a multiyear collaboration to identify and characterize novel CRISPR-Cas nucleases. The ... gene editing across all applications. , Under the terms of the agreement, Pioneer ...
(Date:10/12/2017)... CA (PRWEB) , ... October ... ... (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform specifically designed ... bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, who made ...
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving ... those living in larger cities are affected by air pollution related diseases. , That ... countries globally - decided to take action. , “I knew I had to take ...
Breaking Biology Technology:
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at VivaTech ... startups and global businesses, taking place in Paris ... will showcase the solutions they have built with IBM Watson ... France is one of the most dynamic ... in the number of startups created between 2012 and 2015*, ...
(Date:4/24/2017)... 2017 Janice Kephart , former ... Strategy Partners, LLP (IdSP) , today issues the ... Trump,s March 6, 2017 Executive Order: Protecting ... can be instilled with greater confidence, enabling the ... refugee applications are suspended by until at least ...
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):